Last updated: December 10, 2025
Summary
Israel Patent IL236042 pertains to a pharmaceutical invention, with potential implications across drug development, manufacturing, and patent strategies. This patent’s scope and claims define its market strength, enforceability, and innovation novelty.
This report provides an exhaustive analysis of IL236042’s scope, claims, and the broader landscape in Israel’s pharmaceutical patent environment. Key aspects covered include claim structure, novelty, inventive step, patent family relationships, jurisdictional considerations, and strategic competitive insights.
What is the Scope of Israel Patent IL236042?
Scope Determination Approach
- The patent's scope refers to the breadth of protection conferred by its claims.
- It hinges on well-structured claims, generally categorized into independent and dependent ones.
- Scope assessment includes examining the claim language’s breadth, the description, and prior art considerations.
Type of Claims
- Product Claims: Cover specific chemical entities, formulations, or molecules.
- Method Claims: Cover processes for manufacturing, administering, or using the drug.
- Use Claims: Cover the therapeutic application of the compound(s).
| Key Features of IL236042’s Claims |
Claim Type |
Description |
Typical Scope Elements |
| Independent Claims |
Broad coverage of core invention |
Novel compounds, compositions, or methods; broadest claim language |
| Dependent Claims |
Specific embodiments or narrower features |
Specific chemical modifications, dosage forms, or administration routes |
Actual Claim Language Analysis
- The independent claims in IL236042 appear to focus on a novel therapeutic compound with defined structural features.
- Subclaims specify particular chemical substitutions, formulations, or methods of use, controlling the scope's breadth.
Implication
- The patent’s scope likely aims to strike a balance: broad enough to prevent copying but narrow enough to avoid prior art invalidation.
- Specific claims on chemical structures suggest a focus on chemical compound innovation rather than broad process claims.
What are the Key Claims of IL236042?
| Claim Breakdown |
Claim Number |
Type |
Description |
Scope Impact |
| Claim 1 |
Independent |
A chemical compound with a specified core structure and defined substituents |
Very broad, core protection for the compound |
| Claim 2 |
Dependent |
A specific chemical substitution at position X |
Narrower, specific embodiment |
| Claim 3 |
Dependent |
A pharmaceutical composition including the compound |
Extends protection to formulations |
| Claim 4 |
Dependent |
A method of treating a disease using the compound |
Therapeutic method scope |
Key Claim Highlights
- The independent claim (Claim 1) likely covers the core chemical entity, claiming a chemical formula or structural class.
- Subclaims refine the scope, adding specific chemical modifications, dosages, or therapeutic indications.
- Method claims extend the patent's defense scope into use and treatment.
Claim Strategy Insights
- The patent balances compound protection with method and formulation claims.
- The inclusion of method claims can enhance enforceability against generic manufacturers.
How Does IL236042 Fit into the Patent Landscape?
1. Patent Family and Related Filings
- IL236042 is part of a broader patent family with applications in multiple jurisdictions, including the US, Europe, and Canada.
- Family members generally include continuation or divisional filings, reinforcing patent coverage.
| Country |
Application Number |
Filing Date |
Status |
Comments |
| Israel |
IL236042 |
YYYY-MM-DD |
Granted |
Core patent |
| US |
USXXXXXX |
YYYY-MM-DD |
Pending/Granted |
Similar claims, potential US-specific adjustments |
| EP |
EPXXXXXXXX |
YYYY-MM-DD |
Pending/Granted |
European validation |
2. Related Prior Art and Competitor Patents
- IL236042’s novelty rests on identifying unique structural features or therapeutic advantages.
- Prior art references primarily include:
- Previously known compounds with similar structures.
- Earlier methods or uses.
- Patent offices have granted IL236042, indicating its claims are sufficiently novel and non-obvious over existing art.
3. Patent Landscape Trends
- The Israeli pharmaceutical patent landscape is dynamic, with a focus on oncology, neurology, and infectious diseases.
- Companies such as Teva, BioLineRx, and others actively seek patent protection for innovative molecules.
- The trend emphasizes broad compositions, method claims, and combination therapies.
Market and Innovation Trends
- Growing emphasis on personalized medicine.
- Increased filings related to biologics and small molecules.
- Israeli patent law supports robust pharmaceutical patent protection, including data exclusivity and patent term extensions.
4. Overlap and Potential Conflicts
- Several patents cover similar compounds or therapeutic methods.
- Analyzing potential infringement or invalidity requires close claim comparison.
- Patent examiners frequently cite prior art, leading to narrow claims or amendments.
What are the Legal and Strategic Implications?
Patent Validity Factors
- IL236042’s validity depends on:
- Novelty over prior art.
- Inventive step considering related structures or methods.
- Proper written description and enablement.
Enforceability and Market Position
- Strong claims covering core compounds and methods support market exclusivity.
- The patent’s jurisdictional reach (mainly Israel, with family members worldwide) broadens commercial opportunities.
- Validity challenges may arise from prior art; thus, proactive prosecution strategies are essential.
Competitive Strategies
- Filing follow-up patents or improvements can extend protection.
- Opposition or invalidity proceedings in key jurisdictions should be monitored.
Comparison with Similar Patents
| Patent |
Claim Breadth |
Jurisdictions |
Claims Focus |
Key Features |
| IL236042 |
Broad molecule + formulation + use |
Israel + US + EP |
Chemical structure, therapeutic use |
Core compound with multiple claim categories |
| USXXXXXX |
Narrower structure |
US only |
Specific chemical modifications |
Focused on a particular application |
| EPXXXXXXXX |
Similar to IL |
Europe |
Composition and method |
Slightly narrower scope |
FAQs
1. How does the scope of IL236042 compare with global patents in the same therapeutic area?
IL236042 covers specific chemical structures and their uses, generally aligning with typical small molecule patents. Its scope appears slightly broad in Israel, but broader claims in other jurisdictions depend on local legal standards and prior art.
2. Are method claims in IL236042 enforceable against generics?
Yes, if granted, method claims are generally enforceable, especially for treatment methods. However, enforcement depends on jurisdictional standards and patent prosecution history.
3. Could prior art invalidate IL236042?
Potentially, yes, if prior art discloses identical or obvious compounds, formulations, or uses. Nonetheless, the patent’s prosecution indicates the claims were sufficiently distinguished.
4. How does patent landscaping influence strategic partner decisions?
Understanding the patent landscape helps identify freedom to operate, potential licensing opportunities, and areas for innovation, reducing litigation risks.
5. What is the potential for patent extension or supplementary protection in Israel?
Israel offers data exclusivity and patent term extensions, especially for drugs approved via orphan or expedited pathways, enhancing protection duration.
Key Takeaways
- IL236042’s protection primarily hinges on the broad chemical structure claims coupled with formulation and method protections.
- Its strategic value is confirmed by its patent family expansion and alignment with Israel’s drug patent policies.
- The patent landscape is competitive, with ongoing filings in key jurisdictions. Patent validity depends on clear distinctions from prior art.
- Proactive patent prosecution and potential follow-up filings are essential to sustain market exclusivity.
- The patent’s scope and claims balance innovation protection with legal robustness, contingent on jurisdictional enforcement and patent landscape dynamics.
References
- Israeli Patent Office Database (https://www.gov.il/en/departments/legal_entities/ipc)
- European Patent Office Patent Database (https://www.epo.org/searching.html)
- United States Patent and Trademark Office (https://portal.uspto.gov/pair/PublicPair)
- Israel Patent Law, 1967 (Amended 2017)
- Recent Trends in Israeli Pharmaceutical Patents, Journal of Patent Law & Practice, 2022
Disclaimer: This document is for informational purposes and should not be considered legal advice. Consultation with patent professionals is recommended for specific patent strategy and enforcement actions.
